WASHINGTON, Sept. 26, 2019 /PRNewswire/ -- New data released today by the National Foundation for Infectious Diseases (NFID) revealed that only 52 percent of US adults plan to get vaccinated against influenza (flu) this season. Representatives from NFID and other leading public health and medical organizations urged the public and healthcare professionals to follow

DALLAS and SAN DIEGO, Sept. 26, 2019 /PRNewswire/ -- AMN Healthcare Services, Inc. (NYSE: AMN), announced today that its wholly owned subsidiary, AMN Healthcare, Inc., intends to make a private offering of $300 million aggregate principal amount of Senior Notes due 2027, subject to market and other conditions

Long-acting and Tumor Targeting MDNA109 Variants Dramatically Improve T-cell Stimulation, Tumor Control and Long Term Memory Response TORONTO, Sept. 26, 2019 /PRNewswire/ - Medicenna Therapeutics Corp.  ("Medicenna" or "the Company") (TSX: MDNA, OTCQB: MDNAF), a clinical stage immuno-oncology company dev

STOCKHOLM, Sept. 26, 2019 /PRNewswire/ -- Oncopeptides AB (Nasdaq Stockholm: ONCO) announced today that the last patient has been included in the OP-106 HORIZON pivotal phase 2 clinical study evaluating melflufen with dexamethasone in patients with relapsed/refractory multiple myeloma (RRMM). Oncopeptides has previously communicated a target enrollment of 150 patients

LAGUNA HILLS, Calif., Sept. 26, 2019 /PRNewswire/ -- Today, Medterra CBD announced it will become the exclusive CBD brand of

NEW YORK, Sept. 26, 2019 /PRNewswire/ -- New York City Economic Development Corporation (NYCEDC) and Deerfield Management, a New York City-based healthcare investment firm, announced a new partnership to redevelop a 12-story building located at 345 Park Avenue South into a life sciences campus as part of

Multi-State, Vertically Integrated National Cannabis Company Announces Industry's First National Program Dedicated to Training Formerly Incarcerated Prisoners for New Employment Opportunities PHOENIX, Sept. 26, 2019 /PRNewswire/ -- 

SUGAR LAND, Texas, Sept. 26, 2019 /PRNewswire/ -- QuVa Pharma, Inc. today announced it is completing the next phase of capacity expansion at its Bloomsbury, New Jersey, state-of-the-art cGMP compliant 503B FDA registered manufacturing facility.  The investment in post compounding and distribution ar

MENLO PARK, Calif., Sept. 26, 2019 /PRNewswire/ --

WAYLAND, Mass., Sept. 26, 2019 /PRNewswire/ -- Candela Corporation, a leading global medical aesthetic device company, announces today the Profound® treatment's launch of the "Bring the Snap Back" campaign.  The campaign includes an educational microsite and a contest to give consumers the chance to bring the snap back to their aging